COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
Research output: Contribution to journal › Review › Research › peer-review
Documents
- Open access article
Final published version, 1.09 MB, PDF document
Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe strain disease, which has rapidly spread worldwide. Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how COVID-19 influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. Here, we review the available evidence for prevalence and incidence of AF in patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discuss disease management approaches and potential treatment options for COVID-19 infected AF patients. (C) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Original language | English |
---|---|
Article number | 100631 |
Journal | IJC Heart and Vasculature |
Volume | 30 |
Number of pages | 8 |
ISSN | 2352-9067 |
DOIs | |
Publication status | Published - 2020 |
- Anticoagulation, Arrhythmia, Inflammasome, Remote monitoring, Thromboembolic risk, OBSTRUCTIVE RESPIRATORY EVENTS, CRITICALLY-ILL PATIENTS, INFLAMMATION, PROMOTES, RECEPTOR, OUTCOMES, ACE2, ARRHYTHMIAS, DYSFUNCTION, AMIODARONE
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 251588892